Ingersoll-Rand Inc. provides air, fluid, energy, and medical technologies globally, with a market cap of $33.7 billion. Shares have declined 2.6% in the past year, but surged 12.2% in 2026. The company faces challenges like tariff-related headwinds and softer growth. However, a recent acquisition of Scinomix has boosted sentiment, leading to a 3.1% stock increase. Analysts expect a marginal decline in EPS to $3.17. Ratings are mixed, with a consensus of “Moderate Buy.” Stifel Nicolaus maintains a “Hold” rating with a price target of $87, suggesting potential upside of 1.4% to $90.07.

Read more at Barchart: What Are Wall Street Analysts’ Target Price for Ingersoll Rand Stock?